107430-91-1

Basic information

• Product Name: 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde
• Synonyms: 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde
• CAS NO: 107430-91-1
• Molecular Weight: 270.371
• Mol File: 107430-91-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde(107430-91-1)
• EPA Substance Registry System: 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde(107430-91-1)

Safety Data

• Hazardous Substances Data: 107430-91-1(Hazardous Substances Data)

Upstream product

• 352647-05-3 3-(adamantan-1-yl)-4-hydroxybenzaldehyde 
• 74-88-4 methyl iodide 
• 104224-63-7 2-(1-adamantyl)-4-bromoanisole 

Downstream Products

• 1041437-72-2 4-methoxy-3-tricyclo[3.3.1.1(0,0)]dec-1-yl benzaldehyde oxime 
• 1041437-74-4 1-(2-methoxy-5-vinyl-phenyl)-tricyclo[3.3.1.1(0,0)]decane 
• 173190-98-2 1-(5-ethynyl-2-methoxyphenyl)adamantine 

Relevant articles and documents

S1P RECEPTORS MODULATORS AND THEIR USE THEREOF

The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.

Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same

A polycyclic aromatic compound having the formula STR1 and its salts have useful therapeutic and cosmetic action particularly in psoriasis. In the formula, X represents --CH=CH--, O or S, R1 represents hydrogen, branched alkyl having 3-15 carbo